|
US2010084110A1
|
|
High performance brake rotor
|
|
IL126819D0
|
|
Use of interleukin-1 inhibitors for manufacture of medicaments for treatment or prevention of interleukin-1 mediated diseases
|
|
WO9501994A1
|
|
Recombinant ctla4 polypeptides and methods for making the same
|
|
US5459048A
|
|
DNA encoding 85kd polypeptide useful in diagnosis of Mycoplasma infections in animals
|
|
WO9406457A1
|
|
Pharmaceutical formulations of interleukin-1 inhibitors
|
|
PH30033A
|
|
Expression of purified ciliary neurorophic factor
|
|
WO9319084A1
|
|
Refolding and purification of insulin-like growth factor i
|
|
ATA127892A
|
|
Nucleic acid sequence and amino acid sequences of CNTF
|
|
AU1674292A
|
|
Pegylation of polypeptides
|
|
AU1235692A
|
|
Methods for treating tumor necrosis factor mediated diseases
|
|
US5188943A
|
|
Method of producing high molecular weight human fibroblast growth factors
|
|
EP0527771A1
|
|
Polypeptides useful in diagnosis of and treatment against mycoplasma infections in animals
|
|
AU7363691A
|
|
Methods for treating interleukin-1 mediated diseases
|
|
ZA9101981B
|
|
Methods for treating interleukin-1 mediated diseases
|
|
ZA9101834B
|
|
Production of biologically active,recombinant members of the ngf/bdnf family of neurotrophic proteins
|
|
HU9201777D0
|
|
Method for producing recombinant human interleukin-1 inhibitor
|
|
US5235043A
|
|
Production of biologically active, recombinant members of the ngf/bdnf family of neurotrophic proteins
|
|
WO9104014A1
|
|
Method for transporting compositions across the blood brain barrier
|
|
EP0434909A2
|
|
Anticoagulant and antihelminthic proteins and methods for the production and use of same
|
|
ZA9005593B
|
|
Tumor necrosis factor(tnf)inhibitor and method for obtaining the same
|
